Herpes zoster prophylaxis with low-dose acyclovir in patients with malignant lymphoma and multiple myeloma treated with autologous stem cell transplantation.

Emin AbbasovBernd MetznerThomas H MüllerJochen CasperChristoph KimmichEduard K PetershofenAndrea RenzelmannBernd RosienRuth TholeAndreas VoßClaus Henning Köhne

Published in: European journal of haematology (2022)

Zoster prophylaxis with low-dose acyclovir over 12 months after ASCT is effective and well tolerated.

Keyphrases

low dose
stem cell transplantation
high dose
multiple myeloma
herpes simplex virus
diffuse large b cell lymphoma
bone marrow
stem cells
newly diagnosed